Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02339012 · ClinicalTrials.gov registry record
Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)
A clinical trial of Healthy Volunteers and Non-Healthy/Non-Frail, sponsored by National Institute on Aging (NIA).
- Recruiting
- Registry status
- 900
- Enrollment target
- 1
- Study location
NCT02339012 is a study of Healthy Volunteers and Non-Healthy/Non-Frail that is actively recruiting participants, run by National Institute on Aging (NIA). The registered enrollment target is 900 participants, above the 479-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02339012, a study of Healthy Volunteers and Non-Healthy/Non-Frail, is actively recruiting participants, sponsored by National Institute on Aging (NIA).
- RECRUITING
- Registry status
- 900 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Biomarkers are substances in people s blood and tissues. They help researchers understand diseases and signs of aging. Scientists want to do more research on biomarkers to find ways to improve quality of life in old age. Objective: \- To learn more about biomarkers and their relationship to aging. Eligibility: \- Adults at least 20 years old who weigh at least 110 pounds and have a body mass index below 30. They must agree that their genetic samples can be collected, studied, and stored. Design: * Participants will be screened with medical history, physical exam, EKG and blood and urine tests. * Participants will have 3-day visits. They will return every 2 years. * All visits include: * Blood and urine collection * Physical performance tests * Health questionnaires * Memory and problem-solving tests * Magnetic Resonance Imaging (MRI) and Computerized Tomography (CT) scans. * Muscle metabolism/ exercise tests * Taste strips * Muscle and/or skin biopsies/ red light therapy * Retinal imaging/ eye tracking * Sleep study * ODD visits also include: * Cytapheresis * Bone marrow aspirate * EVEN visits also include: * Hyperglycemic CLAMP * Lumbar Puncture (LP) * Continuous Glucose Monitor (CGM)
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Aging, Clinical Research Unit - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2015-03-15 |
| Est. Completion | 2099-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02339012
The ClinicalTrials.gov registry entry for NCT02339012 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 900 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 479-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (88% higher). The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 0 interventions.
NCT02339012 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02339012 about?
NCT02339012 is a clinical study titled "Genetic and Epigenetic Signatures of Translational Aging Laboratory Testing (GESTALT)". Background: \- Biomarkers are substances in people s blood and tissues. They help researchers understand diseases and signs of aging. Scientists want to do more research on biomarkers to find ways to improve quality of life in old age. Objective: \- To learn more about biomarkers and their relati...
What is the current status of trial NCT02339012?
This trial is currently recruiting. The enrollment target is 900 participants. The study started on 2015-03-15. Estimated completion is 2099-12-31.
What conditions does trial NCT02339012 study?
This clinical trial studies the following conditions: Healthy Volunteers, Non-Healthy/Non-Frail, Frail.
Who is sponsoring clinical trial NCT02339012?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02339012 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Volunteers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Adaptive Optics Retinal Imaging
RECRUITING
-
A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
RECRUITING · Phase 1
-
Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children
RECRUITING · NA
-
A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.
RECRUITING · Phase 1
-
Children s Growth and Behavior Study
RECRUITING
-
New Heart Imaging Techniques to Evaluate Possible Heart Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.